Journal
Irish medical journalPubMed ID
31535834Abstract
The goal of cancer screening is to detect presymptomatic disease and commence treatment sooner, thereby reducing the incidence of advanced disease and the associated morbidity and mortality . Challenges exist around designing, managing and evaluating national screening strategies. Programs require clear governance, reporting structures, accountability and regular appraisal of staff. The Scally report highlighted the vital role Public health expertise should play in delivering and integrating these services along with managing the flow of patient information between the National Cancer Control Programme and the National Cancer Registry. All screening programmes must have a robust Quality Assurance (QA) process and be able to conduct audit effectively.Item Type
ArticleLanguage
enISSN
0332-3102Collections
Related articles
- Conceptualizing overdiagnosis in cancer screening.
- Authors: Marcus PM, Prorok PC, Miller AB, DeVoto EJ, Kramer BS
- Issue date: 2015 Apr
- Challenges to cancer control by screening.
- Authors: Pollak MN, Foulkes WD
- Issue date: 2003 Apr
- P4 medicine or O4 medicine? The perils of population wide, asymptomatic disease screening.
- Authors: Fiala C, Diamandis EP
- Issue date: 2020 Mar
- One stop screening for multiple cancers: the experience of an integrated cancer prevention center.
- Authors: Sella T, Boursi B, Gat-Charlap A, Aroch I, Liberman E, Moshkowitz M, Miller E, Gur E, Inbar R, Blachar A, Mabjeesh NJ, Rosenfeld O, Sperber F, Reiser V, Kleinman S, Jaffa AJ, Bloch M, Ormianer M, Naumov I, Kazanov D, Kraus S, Galazan L, Arber N
- Issue date: 2013 Apr
- Screening for Ovarian Cancer.
- Authors: Jin J
- Issue date: 2018 Feb 13